HighVista Strategies’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77M | Sell |
28,068
-6,971
| -20% | -$440K | 0.65% | 53 |
|
|
2025
Q1 | $1.86M | Sell |
35,039
-2,387
| -6% | -$126K | 0.72% | 47 |
|
|
2024
Q4 | $2.1M | Hold |
37,426
| – | – | 0.78% | 42 |
|
|
2024
Q3 | $1.96M | Buy |
37,426
+23,064
| +161% | +$1.21M | 0.68% | 46 |
|
|
2024
Q2 | $590K | Hold |
14,362
| – | – | 0.22% | 114 |
|
|
2024
Q1 | $622K | Hold |
14,362
| – | – | 0.22% | 110 |
|
|
2023
Q4 | $660K | Buy |
+14,362
| New | +$660K | 0.24% | 106 |
|
|
2023
Q2 | – | Sell |
-35,478
| Closed | -$633K | – | 151 |
|
|
2023
Q1 | $633K | Hold |
35,478
| – | – | 0.52% | 66 |
|
|
2022
Q4 | $1.03M | Buy |
+35,478
| New | +$1.03M | 0.61% | 41 |
|
|
2021
Q2 | – | Sell |
-24,809
| Closed | -$528K | – | 136 |
|
|
2021
Q1 | $528K | Buy |
+24,809
| New | +$528K | 0.39% | 68 |
|
|
2020
Q3 | – | Sell |
-18,609
| Closed | -$415K | – | 127 |
|
|
2020
Q2 | $415K | Buy |
+18,609
| New | +$415K | 0.34% | 57 |
|